Sunshine Act

Grassley blasts CMS foot-dragging on Sunshine Act

Matthew Arnold November 01, 2011

The Centers for Medicare and Medicaid Services, now a month overdue to issue draft guidelines for reporting pharma-physician contacts as required under healthcare reform legislation, said the department is working on it, but offered nothing in the way of a timeline.

Lilly becomes latest pharma to disclose non-cash transfers

Marc Iskowitz July 29, 2011

Eli Lilly reported paying $48.1 million to 45,440 physicians and/or 1,827 healthcare organizations during the first quarter, most of it for research and educational programs.

In protecting market research, federal exclusion may not always apply

Marc Iskowitz March 25, 2010

Thanks to the work of lobbyists, marketing research-related payments are explicitly excluded from Sunshine legislation enacted Tuesday as part of the healthcare overhaul. But the exclusion may not always apply.

GSK reveals speaker, consulting fees

Marc Iskowitz December 15, 2009

GlaxoSmithKline said it paid nearly $15 million in fees in the second quarter to US healthcare professionals for speaking and consulting services.

Healthcare reform bill clears House

Matthew Arnold July 15, 2009

The House of Representatives' version of the healthcare reform bill, dubbed the America's Affordable Health Choices Act of 2009, includes the provisions of the Physician Payment Sunshine Act, which would mandate sweeping transparency measures for pharmas.